et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J. Natl. Cancer Inst.
96, 1030–1036 (2004).
et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology
129, 565–576 (2005).
et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat. Genet.
39, 605–613 (2007).
Lewis, S.J. & Smith, G.D.
Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol. Biomarkers Prev.
14, 1967–1971 (2005).
Hiyama, T., Yoshihara, M., Tanaka, S. & Chayama, K.
Genetic polymorphisms and esophageal cancer risk. Int. J. Cancer
121, 1643–1658 (2007).
et al. Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res.
69, 7994–8000 (2009).
et al. Multiple ADH genes are associated with upper aerodigestive tract cancers. Nat. Genet.
40, 707–709 (2008).
et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet.
7, e1001333 (2011).
et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology
137, 1768–1775 (2009).
et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet.
42, 759–763 (2010).
et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet.
42, 764–767 (2010).
et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet.
43, 679–684 (2011).
Panagiotou, O.A. & Ioannidis, J.P.
What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int. J. Epidemiol.
41, 273–286 (2012).
et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet.
42, 570–575 (2010).
et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int. J. Cancer
129, 2473–2484 (2011).
Gene-environment interactions in human diseases. Nat. Rev. Genet.
6, 287–298 (2005).
et al. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int. J. Cancer
58, 192–196 (1994).
Kim, R., Emi, M., Tanabe, K. & Murakami, S.
Role of the unfolded protein response in cell death. Apoptosis
11, 5–13 (2006).
Koong, A.C., Chauhan, V. & Romero-Ramirez, L.
Targeting XBP-1 as a novel anti-cancer strategy. Cancer Biol. Ther.
5, 756–759 (2006).
et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res.
64, 5943–5947 (2004).
et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J. Hepatol.
38, 605–614 (2003).
Antoni, L., Sodha, N., Collins, I. & Garrett, M.D.
CHK2 kinase: cancer susceptibility and cancer therapy—two sides of the same coin?
Nat. Rev. Cancer
7, 925–936 (2007).
Dall′Olio, F., Chiricolo, M. & Lau, J.T.
Differential expression of the hepatic transcript of β-galactoside α-2,6-sialyltransferase in human colon cancer cell lines. Int. J. Cancer
81, 243–247 (1999).
et al. Enhanced expression of α 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma. Gynecol. Oncol.
89, 395–401 (2003).
et al. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res.
58, 4066–4070 (1998).
Pousset, D., Piller, V., Bureaud, N., Monsigny, M. & Piller, F.
Increased α 2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma. Cancer Res.
57, 4249–4256 (1997).
World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective (AICR, Washington, DC, 2007).
et al. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?
61, 8601–8610 (2001).
Fatayerji, N., Engelmann, G.L., Myers, T. & Handa, R.J.
In utero exposure to ethanol alters mRNA for insulin-like growth factors and insulin-like growth factor-binding proteins in placenta and lung of fetal rats. Alcohol. Clin. Exp. Res.
20, 94–100 (1996).
et al. Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol. Clin. Exp. Res.
34, 840–852 (2010).
et al. Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol.
35, e91–e99 (2011).
et al. Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey. Br. J. Cancer
103, 1085–1088 (2010).
et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J. Natl. Cancer Inst.
92, 1753–1763 (2000).
et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer
9, 269 (2009).
et al. Relevance of N-nitrosamines to esophageal cancer in China. J. Cell Physiol. Suppl.
4, 51–58 (1986).